Cereno Scientific gets FDA clearance for phase IIb PAH trial
Go back to Cereno Scientific gets FDA clearance for phase IIb PAH trial| BARNES GROUP, Inc. (NYSE: B) | Delayed: 40.82 +0.27 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.55 | 52 Week High | $44.27 | |||
| Open | $40.35 | 52 Week Low | $30.07 | |||
| Day High | $41.34 | P/E | 31.16 | |||
| Day Low | $40.14 | EPS | $1.31 | |||
| Volume | 7,127,699 | |||||



